Icon
+91 94997 68112
Login Register

Narcan - (4 mg/Spray; Spary, Metered, Nasal)

Naloxone Hydrochloride Adapt Pharma
4 mg/Spray; Spary, Metered, Nasal
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
Indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids
Yes
**** ** *** ***** ** **** **** ** **** ****** '*** (***** **, ****) *** *** ************ *********** ** ********* ** **** **** ***** ** ******* '*** ******** ** *** **** *** ** '*** ****** *** ** *** **** ** *** **********. ***** ******* (***** **, ****) *** ****** ** *** *, **** *** ****** ** **. **** ***** **** ** **** '*** ****** *** *** *********. ***** **** ***** **** ** **** ******* '***, '*** **** ******** ** ***** **, **** *** ***/***** ****** *** *** *********. *** ********** ********* **** **** ***** ** ****** ****** ** ***** ****. ****** *** ********** ** ** ****** ****, **** *** ********. **, **** ** ******** *** *** **** ***********. ******* **** ***** * **** ** *** *** *********. *****, ***** ****** ******* **** *******, ********* ** ********** ******* *** ****** ******* ** *** *, **** ** **. ******** ****** ** ******** ************* ** ******* *******. *****, * ********* ** ****** ** ***** ** **** *** ******* ***** ****** **** '***, '***, '***, '*** *** '*** ******* *** *******.
Narcan Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
**** *** ** ** *** ** ** ******* ******* *** ********* *** ** ** *** ** ** *** ** **
******* ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ *** ***** **, **** *** ** ** ******** ******** '** ****' ** *** **, ****
******* ** \ ** ***** **, **** ******* ******** ******** ** *** **, ****
  1. *** **, **** : * **** ** *****
  2. *** **, **** : **** ******** ***** ****** ***** *** **** ** **** ****** '*** (***** **, ****).
  3. *** **, **** : ***** ****** ***** * **** ******* **** ** ******** ***** ** **.
  4. *** *, **** : ***** ****** ***** * ** ****** *** (*) ******* ******** ******* ******** ** ********** (**) ******** ******** ** ******* ******** *************** (**), ******, ********* *** *********, ************* *** ******** (***) ****, ** ***-*** ******, ****** *** ****, ** ******* *** ****************** ** ******* ** ******** *** *** ** ******** ********* ****** **** (***); (**) *** ** ******* *** ******* ** ******** ************ ***** *** *** ****** ** ***** **** ******** *** ****** * ****** ******** **** ************ *** ******** ** **** * ******* ***********; *** (***) *** ******* *********** ***** **** ************.
  5. *** **, **** : **** ******** ********* **** ** ****** ******* ******* ( ****** ** *** *, **** *** ** ***** **, ****).
  6. *** **, **** : ***** **** **** ** ** ** **.
  7. *** **, **** : **** ******** ***** ***** *** **** ** **** ******* '***, '*** **** ******** ** ***** **, **** *** ***/***** ******.
  8. *** *, **** : ***** ***** * **** ******* **** ** ******** ***** ** **.
  9. *** **, **** : *** **** ****** ******** **** *** *** ************ ******** *** ***** ***** **** ****** (************ ****) ** ****-***-******* ******.
  10. *** ** **** : ******* ******** ***** ** ***** *** **** ** ************* **** ****** ******** (***** ** ****), ******* (***** **, ****), ******* (***** **, ****), ******* (***** **, ****), ******* (***** **, ****), ******* ((***** **, ****)
  11. *** **, **** : ***** ****** ***** * **** ******* ******* ** ** ** *** ******.
  12. *** **, **** : ******* ****** ***** ****** ***** *** **** ** ************* **** ****** ******** (***** ** ****).
  13. *** *, **** : ***** ****** **** * **** ******* ******* ** ** ** *** ******.
  14. *** **, **** : **** *** ********. *****://***.**********.***.***/**********_****/*********/****/******************.***
  15. *** *, **** : ***** ****** ******* **** *******, ********* ** ********** ******* *** ****** ******* ** *** *, **** ** **.
  16. *** **, **** : * ********* ** ****** ** ***** ** **** *** ******* ***** ****** **** '***, '***, '***, '*** *** '*** ******* *** *******.
  17. *** **, **** : ******* ******** *** ******* ** ******. ** ****** ** *** ********* ** ****'* ****** ** ****.
  18. *** **, **** : ***** ****** *** **** ******* ********** **** ******* '*** *** '*** ** ******* *****.

Narcan - (2mg/Spray; Spray, Metered, Nasal)

Naloxone Hydrochloride Adapt Pharma
2mg/Spray; Spray, Metered, Nasal
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
NARCAN (naloxone) is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids
Yes
**** ** ***. **** ***** * **** ** *** *** *********. ** ****** **** **** **** ****** ** *** ****. *** *** ******* ** ********* ** ************. **** ******* ******** ****** ***/***** **-****. ** ** *** ****** **** ** ****** *** ***/***** ******* **** ********.
Narcan Patent 1 Patent 2
**** ********* ** ***** ** **** ********* ** ***** ** ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** *** *, **** ********* ** ****** ** **** **** ****** **** ********
  1. *** **, **** : **** ** ***** *** ******* ** ******* *** *******
  2. *** **, **** : **** ******** ***** ****** ***** **'* **** ** ****** ** ****** '*** *** '***
  3. *** *, **** : ***** ****** ***** * **** ******* **** ** ******* '*** *** '***
  4. *** **, **** : ***** (******) ********* ********** **** ****. ** ****** ** ** ** ** ****** ** ****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.